Related Experiment Video
Updated: Jun 18, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Prehypertension: is it relevant for nephrologists?
Rigas G Kalaitzidis1, George L Bakris
1Hypertensive Diseases Unit, Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, The University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA.
Insights
Prehypertension increases cardiovascular disease risk. Early intervention focusing on blood pressure and albuminuria monitoring is crucial for preventing chronic kidney disease progression, especially in diabetic patients.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Prehypertension is linked to increased cardiovascular disease risk.
- Patients with comorbidities face higher chronic kidney disease (CKD) risk with prehypertension.
- Lifestyle modifications for prehypertension show limited long-term adherence and impact.
Purpose of the Study:
- To evaluate the impact of renin-angiotensin system blockers on CKD outcomes in prehypertension.
- To investigate the relationship between albuminuria, blood pressure, and CKD progression in diabetic patients.
- To highlight the importance of early intervention and monitoring for CKD prevention.
Main Methods:
- Review of data from natural history studies in type 1 diabetes patients.
- Analysis of blood pressure and albuminuria changes in relation to CKD progression.
- Assessment of pharmacological therapy benefits on CKD markers like microalbuminuria.
Main Results:
- Renin-angiotensin system blockers show benefits on microalbuminuria in prehypertension with target organ damage.
- Albuminuria increases can precede prehypertensive blood pressure increases in type 1 diabetes.
- Systolic blood pressure above 125 mm Hg within the microalbuminuria range predicts nephropathy.
Conclusions:
- Early blood pressure intervention and albuminuria monitoring are vital for CKD prevention.
- Nephrologists must emphasize the importance of managing prehypertension and albuminuria to colleagues.
- Further data on hard renal endpoints are needed for pharmacological interventions in prehypertension.
Abstract:
Blood pressure (BP) in the prehypertensive range is associated with an increased risk for cardiovascular (CV) disease. Patients with co-morbidities are at greater risk for chronic kidney disease (CKD) development in the presence of prehypertension. Lifestyle changes can alter the natural history of prehypertension; however, long-term adherence is rare and thus, their impact on outcomes is limited. Pharmacological therapy in patients with prehypertension and demonstrable target organ damage with blockers of the renin-angiotensin system has demonstrated benefits on markers of CKD outcomes such as microalbuminuria. There are no data, however, on 'hard end points' such as doubling of creatinine or need for renal replacement therapy. In patients with diabetes, monitoring changes in albuminuria, along with assessment of BP in the prehypertensive range, is important to optimize early management and impact the attenuation of CKD progression. Data from natural history studies in patients with type 1 diabetes indicate that increases within the microalbuminuria range antedate increases in BP within the prehypertensive range. Even within the microalbuminuria range, however, systolic BP increases above 125 mm Hg are predictive of nephropathy. Thus, nephrologists need to ensure that their colleagues appreciate the importance of not only early BP intervention but also of monitoring albuminuria changes in order to have maximal impact on CKD prevention.
Related Concept Videos
Hypertension I: Introduction
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management
Hypertension II: Pathophysiology
Diabetic Nephropathy